To further evaluate the impact of DCs uploaded with NPMc+ NETs on AML, NPMc+ mice were implanted subcutaneously with the leukemia cell line C1498 with mutant NPM1 (C1498-NPMc+) followed by a treatment with NPMc+ NETs/DC vaccine. Here, NPM1 is linked to acute myeloid leukemia.